AIM

Conviction 0HealthcareScan · Mon, Aug 10, 2026

AIM$0.2646-7.29%

ResistanceSupportVol 14

Vol MA14 1.48M

May 11May 28Jun 16Jul 6Jul 23Aug 10

AIM ImmunoTech Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.aimimmuno.com ↗

Price0.2646

Change-7.29%

Gap-7.85%

Rel volume0.15×

Avg volume1.21M

Avg $ vol321.24K

SMA 200.2576

SMA 500.3520

SMA 2000.8832

Price vs 50-24.82%

Price vs 200-70.04%

MA stackbearish

50/200 cross—

Supertrenddown · 0.3105

RSI (14)46

MACD hist0.01

MACD cross—

Stoch %K / %D47 / 61

ADX (14)13

+DI / −DI21 / 15

RSI divergence—

MACD divergenceBullish

ATR %+12.15%

ADR %8.03%

52w high2.88

52w low0.2327

From 52w high-90.81%

Above 52w low+13.71%

New 52w highNo

SqueezeOn · 24d

Bollinger width21.10%

%B0.63

Donchian pos47.09%

Donchian high0.3000

Donchian low0.2331

AVWAP (52w high)0.6372

vs AVWAP high-58.47%

AVWAP (52w low)0.5669

vs AVWAP low-53.32%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d0.15×

Avg vol (14d)1.48M

Avg vol (20d)1.21M

Avg $ vol (20d)321.24K

Market cap8.05M

RS 3m (vs SPY)-54.73%

RS 6m (vs SPY)-90.91%

RS line new highNo

Trend template0/8

Technical rank8.5

1 week+0.23%

1 month-6.50%

3 months-21.69%

6 months-76.79%

1 year-90.27%

YTD-77.76%

P/E-0.58

P/B1.04

P/S91.53

P/FCF-0.73

EPS-8.62

Div yield—

ROE-180.24%

ROA-109.64%

Debt/Eq0.49

Current2.11

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-48.24%

EPS growth19.41%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.99M

Revenue26K

Net income-3.79M

Gross profit—

Free cash flow-10.97M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out24.33M

Employees21

ListedThu, Nov 2, 1995

Free float7.83M

Float %96.1%

Short interest1.54M

Days to cover2.4d

Short volume39.2%

Squeeze score52 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank8.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.3041

Support0.2354

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AIM

All disclosures →

No recent disclosed trades by Congress in AIM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AIM

No recent insider (Form 4) filings in AIM. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in AIM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.